Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)
Dexcom's (DXCM) quarterly Non-Current Deffered Revenue came in at $600000.0 in Q4 2012, up 100.0% year-on-year from $300000.0 in Q1 2012, and up 5.45% on a QoQ basis from $569000.0 in Q3 2012.
Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012) Analysis & Trends
Dexcom (DXCM) has 2 years of Non-Current Deffered Revenue data on file, last reported at $600000.0 in Q4 2012.
- On a quarterly basis, Non-Current Deffered Revenue rose 100.0% year-over-year to $600000.0 in Q4 2012; TTM through Dec 2012 was $600000.0, a 100.0% increase from a year earlier, with the FY2012 full-year figure at $600000.0, up 100.0% from the prior year.
- Non-Current Deffered Revenue for Q4 2012 stood at $600000.0, up from $569000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for DXCM reached as high as $834000.0 in Q1 2012 and fell as low as $300000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 702,000.00 |
| Mar 31, 2012 | 834,000.00 |
| Dec 31, 2011 | 300,000.00 |